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DevelopmentIn the vertebrate central nervous system (CNS), astrocytes are the most abundant and functionally diverse
glial cell population. However, the mechanisms underlying their speciﬁcation and differentiation are still
poorly understood. In this study, we have deﬁned spatially and temporally the origin of astrocytes and
studied the role of BMPs in astrocyte development in the embryonic chick spinal cord. Using explant
cultures, we show that astrocyte precursors started migrating out of the neuroepithelium in the mantle layer
from E5, and that the dorsal-most level of the neuroepithelium, from the roof plate to the dl3 level, did not
generate GFAP-positive astrocytes. Using a variety of early astrocyte markers together with functional
analyses, we show that dorsal-most progenitors displayed a potential for astrocyte production but that
dorsally-derived BMP signalling, possibly mediated through BMP receptor 1B, promoted neuronal
speciﬁcation instead. BMP treatment completely prevented astrocyte development from intermediate spinal
cord explants at E5, whereas it promoted it at E6. Such an abrupt change in the response of this tissue to BMP
signalling could be correlated to the onset of new foci of BMP activity and enhanced expression of BMP
receptor 1A, suggesting that BMP signalling could promote astrocyte development in this region.ein(s); CNS, central nervous
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
The construction of the central nervous system (CNS) involves the
coordinated production and differentiation of speciﬁc neuronal and
glial cells. During development, neural progenitors that initially form
the undifferentiated neuroepithelium of the neural tube, sequentially
generate neurons and glial cells. In the embryonic spinal cord,
extrinsic signalling molecules and cell-intrinsic factors that instruct
these multipotent neural progenitors to generate the remarkable
diversity of specialized neurons and oligodendrocytes have been well
established (Rowitch, 2004). In contrast, although astrocytes consti-
tute the most abundant cell type in the CNS and play diverse and
important functional roles, ontogenic mechanisms leading to the
development of this lineage are still poorly understood (Kessaris et al.,
2008). Among the early putative markers of the astrocyte lineage
recently identiﬁed, some display a rather broad pattern of expression
such as the zeta/beta tyrosine phosphatase receptor (Ivanova et al.,
2004), the CCAAT box element-binding transcription factor nf1a
(Deneen et al., 2006), the HMG protein sox9 (Stolt et al., 2003), the
zinc ﬁnger protein klf15a (Fu et al., 2009). Other markers, on thecontrary, exhibit restricted expression patterns in the neuroepithe-
lium such as the Fibroblast Growth Factor Receptor 3 (fgfr3, (Pringle
et al., 2003), the glutamate–aspartate transporter GLAST (Shibata
et al., 1997), and the homeobox protein pax6 (Hochstim et al., 2008;
Sakurai and Osumi, 2008)), suggesting a restricted origin of astrocyte
precursors (APs). Therefore, the localization of APs in the spinal cord
is not yet clearly deﬁned and astrocytes may not be generated
throughout the dorso-ventral extent of the neuroepithelium. In
addition, APs appear to be initially generated as separate subpopula-
tions based on their homeodomain transcriptional code (Hochstim
et al., 2008). Thus, it is necessary to discover new markers that will
permit to distinguish these different populations and help to
understand the intrinsic and extrinsic mechanisms that drive AP
speciﬁcation.
Multiples extrinsic signalling molecules have been involved in the
patterning of the CNS such as the ventralizing signal, Sonic Hedgehog
(Shh) (Dessaud et al., 2008), and dorsally secreted bone morphoge-
netic proteins (BMPs) (Chizhikov and Millen, 2005; Liu and
Niswander, 2005). BMPs are members of the TGFβ family that play
pleiotropic roles in nervous system development, from apoptosis at
early stages, to proliferation and promotion of neuronal and glial fates
in a sequential manner (Chen and Panchision, 2007). In particular,
BMP signalling seems to enhance neuronal speciﬁcation and/or
differentiation of early neural precursors from various origins such
as E12–E14 neocortical precursor cells within the ventricular zone (Li
Fig. 1. Origin of astrocytes in the spinal cord. A: Schematic representation of the
dissection of mantle layer (ML) from live vibratome sections of the embryonic spinal
cord. Explants are dissected free of neuroepithelial cells (NE). B–C: Confocal images of
mantle layer explants dissected at E4 (B), E7 (C), cultivated until an age equivalent to
E12 and subjected to double, GFAP (green), HuC/D (red) immunostainings. Explants
contained HuC/D-positive neurons at all stages. On explants dissected at E4, no GFAP-
positive astrocytes could be detected (B). At E7, more than 80% of the explants had
developed a dense GFAP-positive astrocyte population (C). D: Percentage of explants
containing GFAP-positive astrocytes at each time point analyzed. E: Schematic
representation of the dissection of the E4 spinal cord in three different domains:
dorsal-most spinal cord (D), intermediate spinal cord (I), and ventral-most spinal cord
(V). F, G: Examples of an incision made (arrowheads) on E4 spinal cord vibratome
sections to illustrate the dissection. F: The vibratome section was processed for
immunostaining against Pax7 (green) and Pax6 (red). G: Immunostaining against Pax7
(green) and Olig2 (red). H–J: Confocal images of double immunostainings using anti-
HuC/D (red) and anti-GFAP (green) on ventral-most (H), on intermediate (I), or on
dorsal-most explants (J) after 8 days in culture. Both intermediate and ventral-most
explants contained numerous neurons and astrocytes (H, I). In contrast, dorsal-most
explants generated many neurons but did not sustain the development of GFAP-
positive astrocytes (J). K, L: In situ hybridization of chick spinal cord sections at E8 for
ngn2 (K) and ebf2 (L). Scale bars represent 100 µm.
612 E. Agius et al. / Developmental Biology 344 (2010) 611–620et al., 1998), early stage SVZ neural stem cells (Liu et al., 2004a), adult
neural stem cells in vivo (Colak et al., 2008) and neural precursors of
E2 chick neural tube, where BMPs are the key regulators of dorsal
neuronal identity (Timmer et al., 2002). On the other hand, BMPs also
control several aspects of astrocyte development: they have been
clearly established as inducer of the AP fate from perinatal mouse
forebrain neural progenitors (Gross et al., 1996; Mabie et al., 1999;
Gomes et al., 2003), optic nerve derived O2A cells (Mabie et al., 1997)
or adult spinal cord glial restricted progenitors (Cheng et al., 2007).
They have also been shown to control terminal differentiation of
astrocytes (Chen and Panchision, 2007; See et al., 2007). BMPs bind to
several serine threonine kinase receptors (BMPR) that will activate
signal transduction through the speciﬁc activation of the Smad family
of protein (Shi andMassague, 2003). Double loss of function studies of
BMP receptors bmpr1a and bmpr1b have illustrated their requirement
in the control of astroglial development by BMP signalling (See et al.,
2007). In contrast, BMPs play an inhibitory role on astrocyte
development on isolated E14 rat dorsal spinal cord cultures
(Chandran et al., 2003). This shows that BMP signalling also plays
pleiotropic roles on astroglial development, probably in a context-
dependent manner (Kessaris et al., 2008).
In this study, we have addressed the question of the spatial and
temporal origin of APs in the embryonic chick neural tube and the role
of BMPs in the emergence of astrocytes. We show that at E4, neural
precursors populating the dorsal-most region of the spinal cord
neuroepithelium do not generate GFAP astrocytes. This is due, at least
in part, to active dorsal BMP signalling, since the inactivation of BMP
by Noggin is sufﬁcient to induce expression of early astrocyte markers
in vivo, and astrocyte development in explants cultures. We further
show that BMP activity can block astrocyte development in the
intermediate Pax6 positive region of the neuroepithelium between E4
and E5 but stimulates astrocyte emergence in this region after E6. This
abrupt change in BMP effect can be correlated with the appearance of
new foci of endogenous BMP signalling in the intermediate and
ventral spinal cord.
Materials and methods
Materials
Fertilized chick eggs (White Leghorn, commercial source) were
incubated at 38 °C in a humidiﬁed incubator and embryoswere staged
according to Hamburger and Hamilton (1992).
Explant cultures
Embryonic chick or mouse spinal cord explants were obtained
using cervico-brachial spinal cord dissected free of surrounding tissue
at various stages, opened along the dorsal midline, and sectioned
transversally with a vibratome (Leica) in 3% PBS/low melting point
agar (Euromedex) in PBS. To address the question of the origin of APs,
transverse sections of E4 spinal cord were dissected into three
domains along the dorso-ventral axis: dorsal-most (D), intermediate
(I), and ventral-most domains (V in Fig. 1E). To deﬁne the population
of precursors included into each type of explant, an incision wasmade
at the proper level of the neuroepithelium (visualized by the arrow-
head in Figs. 1F and G). The spinal cord sections were immediately
ﬁxed and subjected to immunostaining with the appropriate markers
of precursor subpopulations (Pax7, Pax6, Olig2). For cultures, after
microdissection (visualized by the dotted line in Figs. 1F and G), the
explants were grown until the indicated age. In all culture experi-
ments, explants were grown in DMEM (Gibco BRL) supplemented
with 10% FCS (Sigma), on collagen gel-coated 12-mm plastic cover-
slips placed in 14-mm four-well dishes (Nunc). The recombinant
mouse BMP4 protein (Biogen) was used at concentration of 5 nM and
the recombinant mouse noggin/Fc chimera (R&D system)was used at
613E. Agius et al. / Developmental Biology 344 (2010) 611–620concentrations of 12 nM for neuroepithelial cultures. The culture
medium was renewed every 48 h.
Electroporation
Electroporation was performed as previously described (Itasaki
et al., 1999). In summary, 1 to 2 μg of DNA was injected in the caudal
neural tube using a glass pipette. Electrodes were positioned on each
side of the embryo and four to ﬁve pulses at 25 V were applied to
allow unilateral entry of the DNA into the neural primordium, the
untransfected half constituting the control. Themouse noggin cDNA (a
gift from R. Harland) was inserted into pCIG (a gift fom A. McMahon).
This vector contains a CMV enhancer, β-actin promoter, and an
internal ribosome entry site sequence (IRES), followed by a nuclear
localized green ﬂuorescent protein (GFP) (Megason and McMahon,
2002). For control electroporations were carried out with pCIG vector
without insert. The pCDNA containing mouse BMP4 cDNA (a gift from
P. Bovolenta) was co-electroporated with pCIG.
Staining procedures
Embryos and spinal cord explants were ﬁxed in 3.7% formaldehyde
in PBS, at 4 °C, for 4 h or 30 min, respectively, and processed for
immunohistochemistry. For in situ hybridization, the tissues were
ﬁxed overnight at 4 °C. After ﬁxing, the embryos were sectioned at
60–80 µm on a vibratome (Leica) before being processed. Detection of
intracellular antigens HuC/D, Glial Fibrillary Acidic Protein (GFAP),
phosphoHistone3, phosphoSmad1, glutamate aspartate receptor
(Glast), S100β, were performed on permeabilized tissues using
Triton-X 100 (0.5% in PBS) and primary antibody was applied at the
appropriate dilution in 0.1% Triton-X 100/PBS and incubated
overnight at 4 °C. After incubation, the sections were rinsed in PBS
and further incubated for 30 min with biotinylated secondary
antibody directed against either mouse or rabbit Ig (Amersham,
diluted 1:50). After rinsing, biotinylated antibodies were revealed by a
30 min incubation with ﬂuorescein (FITC)- or rhodamine (TRITC)-
coupled streptavidin (Amersham, diluted 1:50). To detect simulta-
neously GFAP and HuC/D, immunohistochemistry was performed
sequentially, using ﬁrst anti-GFAP antiserum then biotinylated
secondary antibody and ﬂuorescein isothiocyanate (FITC)-coupled
streptavidin as described above; this was followed by anti HuC/D-
antibody, revealed with goat anti-mouse Alexa-546 antibody (Mo-
lecular Probes).
For BrdU staining, embryos and organotypic cultures were
incubated for 45 min with BrdU (BrdU labelling and detection kit,
Roche) at the end of the culture period. The tissues were then ﬁxed for
4 h and processed for BrdU staining according to the manufacturer's
instructions. TUNEL assay (Roche) was performed as recommended
by the manufacturer.
Sections and neuroepithelial explants were analyzed with a Leica
SP2 confocal microscope, equipped with argon and helium-neon
lasers and appropriate ﬁlter combinations for ﬂuorescein and
rhodamine, respectively. In all cultures, labelled cells were counted
and results are expressed as the mean±s.e.m number of labelled cells
per explant. Signiﬁcance of the results was analyzed using the
Student's t-test.
Antibodies
Astrocytes were evidenced using an antiserum directed against
Glial Fibrillary Acidic Protein (GFAP; DAKO A/S, Denmark) used at a
dilution of 1:500, glutamate aspartate receptor (GLAST) used at 1:500
(gift of M. Watanabe) or S100β (rabbit anti-S100β Swant,
Switzerland) used at 1:5000. Oligodendrocytes were analyzed using
an antiserum directed against olig2 (Millipore) used at 1/1000.
Differentiated neurons were identiﬁed using the anti-HucC/D at adilution of 1:500 (molecular probes). Mitotic ﬁgures were detected
using an antibody directed against the PhosphoHistone 3 (PH3)
antibody used at a dilution of 1/500 (Upstate Technology). Ventricular
cell were visualized using Sox9 antiserum diluted at 1:2000 (Gift of P.
M. Wegner). The following monoclonal antibodies (culture super-
natants) were obtained from the Developmental Studies Hybridoma
Bank. Ventricular cell subpopulations were visualized either with the
anti-Pax7 antibody used at 1:2 dilution (74.5A5, Ericson et al., 1996),
or the anti-Pax-6 antibody used at 1:2 dilution (Ericson et al., 1997).
In situ hybridization
Ngn2, ebf2, Fgfr3, glast,wnt7b, bmpr1a and bmpr1b transcripts were
analyzed using the antisense digoxigenin RNA probe. Ngn2 cDNA was
a gift from J. Rubenstein, Fgfr3 cDNA was a gift from O. Delapeyriere.
Ebf2 cDNA was a gift from A. Vincent. bmpr1a and, bmpr1b cDNAs
were a gift of P. Bovolenta. The whole-mount in situ procedure was
performed according to Wilkinson (1992).
Results
Timing of AP speciﬁcation
A prerequisite to understand the mechanisms of astrocyte
development in the embryonic spinal cord is to deﬁne when and
where APs leave the neuroepithelium to populate the mantle layer.
We analyzed the ability of mantle layer explants, devoid of
neuroepithelium, isolated at various developmental stages to auton-
omously generate GFAP-positive astrocytes (Fig. 1A). In this para-
digm, only explants that contained cells engaged towards the
astrocyte differentiation pathway, will be able to generate these
cells. Mantle layer explants from E4 to E7 were carefully micro-
dissected free of neuroepithelial cells (Soula et al., 2001) and plated in
culture. We analyzed the ability of these explants to generate
astrocytes and neurons, using expression of Glial Fibrillary Acidic
Protein (GFAP), a mature astrocyte marker, and of HuC/D, a pan
neuronal marker, after a period of time corresponding in all cases to
an equivalent of E12 in vivo, a developmental stage when GFAP+
astrocytes can be readily detected in the embryonic spinal cord (de
Vitry et al., 1981; Goulding et al., 1993; Kim et al., 1996; Agius et al.,
2004). In explants dissected out at E4 (n=21) and cultivated 8 days,
differentiation of GFAP-expressing cells was never observed while
HuC/D+ neurons were invariably detected in the explants (Fig. 1B)
indicating that migration of cells capable to differentiate into GFAP-
positive astrocyte had not yet occurred. Autonomous production of
astrocytes from the mantle layer was ﬁrst apparent after E5, since a
small fraction (less than 20%) of E5 and E6 explants (n=21 and 45,
respectively) produced few GFAP-expressing cells (quantiﬁed in
Fig. 1D). In marked contrast, a large fraction (80%) of mantle layer
explants (n=15) isolated at E7 developed numerous GFAP-expres-
sing astrocytes over the culture period (Figs. 1C and D). These data
indicate that APs start to be found in themantle layer from E5 and that
a massive production of APs occurs after E6 in the spinal cord mantle
layer.
Neuroepithelial origin of APs in the chick embryonic spinal cord
Since several early markers of glial lineages are expressed
throughout the neuroepithelium, one could expect astrocytes being
produced along the entire extent of the neuroepithelium. To test this
possibility, we analyzed the potential for autonomous astrocyte
production of different spinal cord domain along the dorso-ventral
axis of the spinal cord. We divided the spinal cord into three roughly
equivalent regions, dorsal-most, intermediate and ventral-most,
before APs have started to migrate into the mantle layer i.e. at E4
(Fig. 1D). The type of precursor population present at each level at the
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immunostaining the spinal cord sections with markers of neural
precursors subpopulations (Melton et al., 2004). The dorsal-most
domain (called D in Fig. 1E) containing Pax7+/Pax6− neural
progenitors (green staining Figs.1F and G) corresponds to the region
extending from the roof plate to dl3 dorsal interneurons precursors.
The intermediate domain (called I in Fig. 1E) spans the Pax6+ neural
progenitor domain (red staining in Fig. 1F) and contains dl4 to p2
precursors. The ventral-most domain (called V Fig. 1E) includes the
olig2+ progenitors (red staining in Fig. 1G) and extends from the
pMN to the ﬂoor plate (fp). All explants contained both neuroepithe-
lial progenitors and mantle layer cells (NE and ML respectively in
Fig. 1E). After 8 days in culture, we analyzed the presence of neurons
and GFAP+ astrocytes in the explants. HuC/D+ neurons were
evidenced in all explants, irrespective of the dorso-ventral level
origin of the explants in the spinal cord (Figs. 1H–J). Ventral-most
(Olig2+) and intermediate (Pax6+) explants invariably generated
GFAP+ astrocytes in our culture conditions (Figs. 1H and I). In marked
contrast, explants dissected from the dorsal-most Pax7+/Pax6−
region of the spinal cord were always entirely devoid of GFAP-
expressing cells (Fig. 1J), evenwhen culturesweremaintained for up to
2 weeks (not shown). These results suggest that, in our experimental
conditions (until E12), the dorsal-most Pax7+ neural progenitors do
not generate GFAP+ astrocytes but produce HuC/D+ neurons.
Neuronal generation in this region was conﬁrmed in vivo by analyzing
expression of ngn2, a proneural transcription factor (Sommer et al.,
1996) and of ebf2, a neuronal determination gene (Garel et al., 1997;
Garcia-Dominguez et al., 2003), that have been shown to be down-
regulated in the ventral region of the subventricular zone during the
neuronal/oligodendroglial switch (Danesin et al., 2006). Expression of
these genes was observed in cells lining the intermediate neuroepithe-
lial region, at E5 and E6 (Danesin et al., 2006 and not shown).
Interestingly, the expression of both genes was reduced in the ventral
and intermediate E8 spinal cord (Figs. 1K and L) but remained strongly
expressed in cells lining the dorsal-most domain of the neuroepithelium
indicating that at least part of dorsal neural progenitors are still
producing neurons until E8 (Figs. 1K and L).
Altogether, these results suggest that in the embryonic spinal cord,
APs start to be generated at E5 from the intermediate and ventral-
most regions but are not produced from Pax7+/Pax6− dorsal-most
progenitors which still generate neurons.
Control of astrocytogenesis in the embryonic spinal cord
The absence of astrocyte development from the Pax7+ dorsal-
most domain may be explained either by its intrinsic inability to do so
or by the presence of an inhibitory molecule that would locally
prevent astrocyte production. BMPs are produced by roof plate cells
and are well characterized dorsalizing factors of the neural tube
(Wilson and Maden, 2005), which play a major role in the
speciﬁcation of dorsal neuronal subpopulation in the E2 spinal cord
(Timmer et al., 2002). It is conceivable that they continue to play this
role during later neural tube development, supporting neurogenesis
in the dorsal-most Pax7+ domain while restricting astrocyte
development to the Pax6+ intermediate and olig2+ ventral-most
spinal cord. To test this hypothesis, we cultivated explants of the
intermediate domain in the absence or presence of 20 ng/ml BMP4
protein (Fig. 2A) and analyzed the expression of early and late
astrocytes markers. For early markers, we analyzed the expression of
fgfr3, (Pringle et al., 2003), of GLAST (Shibata et al., 1997), and of
wnt7b, a gene isolated in a chick cDNA library enriched for genes
differentially expressed in the ventral neuroepithelium of E6
embryonic spinal cord (Braquart-Varnier et al., 2004). Wnt7b is
initially expressed around E4 in the intermediate region of the
neuroepithelium (Fig. 2B) and ismaintained at later stages exclusively
in astrocytes migrating in the mantle layer (Fig. 2C) (Agius et al., inpreparation). These three early astrocyte markers are expressed in
partially overlapping domains in the E6 spinal cord (Figs. 2B, D, E). In
intermediate explants, after 2 days in culture in control conditions,
neural progenitors invariably maintained the expression of wnt7b
(Fig. 2F), fgfr3 (Fig. 2H) and GLAST (Fig. 2J). In marked contrast,
addition of 20 ng/ml BMP4 at the time of plating totally abolished
expression of the three genes (Figs. 2G, I, K). We then asked whether
the same effect could be observed when the progenitors were left in
their normal context in vivo. We electroporated a BMP4 expression
vector, pCDNA-BMP4, and observed, 48 h later, a drastic inhibition of
wnt7b expression of (Fig. 2L), together with that of fgfr3 (Fig. 2M), and
GLAST (Fig. 2N). Altogether, these experiments indicate that ectopic
BMP activity is sufﬁcient to reduce the endogenous expression of early
AP markers in neural progenitors of the intermediate region.
The effects of BMP4 were then analyzed using deﬁnitive astrocyte
differentiationmarkers. E4 spinal cord explants from the intermediate
regions cultivated for 8 days in control conditions generated numer-
ous astrocytes evidenced by GFAP (Fig. 2O), GLAST (Fig. 2Q) or S100β
(Fig. 2S) immunoreactivities together with HuC/D-positive neurons
(Figs. 2O and S). BMP4 protein treatment drastically reduced GFAP,
GLAST and S100β immunoreactivities (Figs. 2P, R, T). We quantiﬁed a
7-fold reduction in the percentage of the surface covered by GFAP
immunostaining between control conditions (22.1+/−3%) and
BMP4 treatment (3+/−2.6%) (n=27 explants). In parallel, BMP4
treatment increased HuC/D immunoreactivity, as shown by a 3-fold
increase in the percentage of the surface covered by HuC/D
immunostaining between control conditions (14.3+/−1.5%) and
BMP4 treatment (41+/−7%). BMP4 was not just delaying astro-
cytogenesis in our culture assay since GFAP+ astrocytes were not
detected after 2 weeks of culture (Supplementary Figs. 1A and B).
BMP4 at 5 ng/ml did not affect GFAP expression, indicating a dose-
dependent inhibitory effect of BMP4 on astrocytogenesis (n=13
explants, not shown). Although BMP4 treatment stimulated neuronal
differentiation of neural progenitors, it did not deplete neural
progenitors since the expression of Sox9 (Supplementary Figs. 1B
and C, n=21 explants), a pan-neuroepithelial marker (Stolt et al.,
2005), and Pax7, a BMP4-regulated dorsal progenitor marker
(Goulding et al., 1993; Timmer et al., 2002), were readily detected
after BMP4 treatment, indicating that a large pool of neural
progenitors persisted in the explants under these conditions (Sup-
upplementary Figs. 2D and E, n=23 explants). The absence of
astrocyte development was not due to BMP4-induced cell death since
the number of apoptotic cells evidenced by the TUNEL assay was not
modiﬁed (n=11 explants, Supplementary Figs. 2F and G). BMP4
treatment caused a 2-fold increase in cell proliferation, quantiﬁed
using either the mitotic marker phosphoHistone3 (from 11.6+/−1.8
to 25.6+/−5.1 pH3 positive cells per explant, Supplementary Figs.
2H and I, n=16 explants) or BrdU incorporation analysis (not
shown). Together, these experiments show that in the E4 spinal cord,
ectopic BMP4 signalling is able to inhibit astrocyte development and
reinforce the idea that roof plate-derived BMPsmay be responsible for
the absence of expression of early astrocyte marker in the dorsal
spinal cord and for the lack of astrocyte development in this region.
To challenge this hypothesis, dorsal endogenous BMP signalling
was blocked using the natural antagonist Noggin (Smith et al., 1993).
Noggin activity was ﬁrst tested in vivo, by electroporation of a noggin-
expressing vector, pCIG-Noggin, in neural progenitors in the E2 spinal
cord. Two days after electroporation, we observed a dorsal extension
of the domain of expression of wnt7b (arrowhead in Fig. 3A), as well
as those of fgfr3 (Fig. 3B), and GLAST (Fig. 3C) showing that inhibition
of endogenous BMP signalling in the spinal cord was sufﬁcient to
expand dorsally the expression of early astrocytemarkers. To evaluate
the effect of Noggin on astrocyte differentiation, we explanted the
Pax7+ dorsal spinal cord domain, containing the roof plate, at E4
(Fig. 3D), and cultivated it for 8 days in the absence or presence of
12 nM recombinant mouse Noggin/Fc chimera. As already shown in
Fig. 2. BMP signalling reduces astrocyte marker expression in the embryonic spinal cord. A: Schematic representation of intermediate spinal cord dissection and culture. B–C: In situ
hybridizations of wnt7b on E6 (B) and E8 chick spinal cord (C). D–E: In situ hybridizations on E6 spinal cord for FGFR3 (D) and glast (E). E4 Intermediate spinal cord explants
cultivated for 2 days (F–K) or 8 days (O–T) under control conditions (F, H, J, O, Q, S) or in the presence of 20 ng/ml of BMP4 (G, I, K, P, R, T). In situ hybridizations of wnt7b (F, G),
FGFR3 (H, I), glast (J, K), show that BMP treatment abolished their expression. After 8 days of culture, the explants were subjected to a double anti-GFAP (green), anti-HuC/D (red)
immunostaining (O, P), an anti-glast immunostaining (Q, R) or a double anti-S100β (green), anti-HuC/D (red) immunostaining (S, T). BMP4 protein treatment abolished GFAP-
(compare O and P) Glast-(compare Q and R) or S100β (compare S and T) immunoreactivities and increased HuC/D immunoreactivity (compare O, P and S, T). E2 spinal cord
electroporated with pCDNA-BMP4 (L–N) grown to E4 and subjected to in situ hybridization with wnt7b (L), FGFR3 (M), or glast (N). The electroporated side is on the right. BMP4
electroporation strongly reduced marker expression. Images representative of at least 15 explants in 3 different experiments. Scale bars represent 100 µm.
615E. Agius et al. / Developmental Biology 344 (2010) 611–620Fig. 1, explants in control conditions did not develop GFAP-positive
astrocytes, but displayed numerous HuC/D-positive neurons (Fig. 3E).
The addition of recombinant mouse Noggin/Fc chimera allowed the
development of numerous GFAP-positive astrocytes associated withHuC/D differentiated neurons (n=24 explants, Fig. 3F), indicating
that blocking endogenous roof plate-derived BMP signalling is
sufﬁcient to allow GFAP expression in dorsal explants. Neither cell
proliferation (Supplementary Figs. 1K and L) nor cell death observed
Fig. 3. Noggin stimulates astrocyte marker expression in the dorsal embryonic spinal
cord. E2 spinal cord electroporated with pCIG-Noggin (A–C), and subjected to in situ
hybridization at E4 with wnt7b (A), FGFR3 (F) or glast (C). The electroporated side is on
the right. Noggin electroporation expands expression of the three markers in dorsal
direction (arrowheads). D: Schematic representation of the dorsal spinal cord
dissection and culture. E–F: E4 dorsal spinal cord explants cultivated 8 days under
control conditions (E) or in the presence of 12 ng/ml of Noggin protein (F) and
subjected to a double anti-GFAP (green), anti-HuC/D (red) immunostaining. In control
condition cultures, dorsal explants generated HuC/D-positive neurons but no GFAP-
positive astrocytes (E). With Noggin protein, dorsal explants generated numerous
GFAP-positive astrocytes and HuC/D-positive neurons (F). Images representative of at
least 17 explants in 3 different experiments. Scale bars represent 100 µm.
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ment (n=14 explants, Supplementary Figs. 2M and N). Altogether,
these results strongly suggest that endogenous dorsal BMP signalling
restricts expression of astrocyte markers in the dorsal-most Pax7
domain while maintaining neurogenesis in this region.
Dual BMP4 activity on neuroepithelial progenitors during spinal cord
development
Because BMPs plays pleiotropic roles depending on the develop-
mental stage and status of the responding cells, we tested BMP4 effect
on intermediate explants dissected at various stages from E4 to E7 and
maintained in culture until they reached a total age equivalent to E12.
Under control conditions, GFAP-positive astrocytes and HuC/D-
positive neurons developed in all explants irrespective of the stage
at which they were isolated (Figs. 4B–E). In the presence of 20 ng/mlBMP4 protein, explants dissected at E4 and E5 contained HuC/D-
positive neurons but no GFAP-positive astrocytes conﬁrming the above
observations (Figs. 4F and G). Strikingly, however, explants dissected
after E6 and subjected to BMP4 treatment generated a dense population
of GFAP-positive astrocytes, mingling with HuC/D-positive neurons
(Figs. 4H and I). Quantiﬁcation of GFAP and HuC/D immunoreactivities
showed that BMP4 treatment on E6 explants resulted in a 3-fold
increase in GFAP immunostaining and a 2-fold increase in Huc/D
immunoreactivity (Fig. 4J) compared to control cultures. These opposed
effects of BMPs were not restricted to the chick spinal cord since
comparable restrictive and stimulating activities were obtained using
mouse explants dissected from the intermediate spinal cord at 10.5 dpc
and 13.5 dpc respectively (Figs. 4K–N). These results are consistentwith
the notion that BMP signalling plays different activities on neuroepithe-
lial progenitors depending on their developmental status i.e. inhibiting
astrocyte marker expression on neurogenic precursors (E4–E5) and
promoting their expression during the gliogenic period (E6–E7).
This abrupt change in the response of intermediate spinal cord
tissue between E5 and E6 prompted us to analyze whether
endogenous BMP signalling could be modiﬁed during this develop-
mental period. We analyzed sites of active BMP signalling at various
stages by using an antiserum directed against receptor-phosphory-
lated Smad1/5/8 (Persson et al., 1998; Faure et al., 2000, 2002). At all
stages analyzed (E4, E6 and E8), a strong dorsal domain of
phosphorylated Smad1 immunoreactivity could be observed around
the roof plate (arrowhead in Figs. 5A–C), showing that active BMP
signalling is maintained beyond E2 (Faure et al., 2000). Strikingly,
however, two new and strong phospho-smad1 immunoreactive
domains were detected at E6 and E8 in the intermediate and
ventral-most regions of the neuroepithelium (arrows in Figs. 5B and
C). At both stages, a domain of lower expression was observed in the
Olig2 domain (asterisks in Figs. 5B and C). Thus, expression of the
phosphorylated form of Smad1 in the ventral neuroepithelium can be
correlatedwith themodiﬁcation of BMP effects on intermediate spinal
cord explants (Fig. 4).
To further document the BMP signalling pathway at these stages, we
analyzed the expression of BMP receptors 1A and 1B which have been
shown to control the production and fate of dorsal precursor cells in a
sequential manner (Panchision et al., 2001). Expression of Bmpr1bwas
restricted to the dorsal neuroepithelium at all stages analyzed, between
E4 and E8 (Figs. 5D–F), and largely overlappedwith the Pax7 expression
domain (shown at E6, inset in Fig. 5E). Bmpr1a expression was more
dynamic (Figs. 5G–I). At E4, a low level of Bmpr1a expression was
detected along the dorso-ventral axis of the neuroepithelium, with a
slight ventro-dorsal gradient (Fig. 5G). At E6, its expressionwas strongly
reinforced in the intermediate and ventral-most region of the
neuroepithelium, except in the Olig2 domain (arrow and inset in
Fig. 5H). At E8, Bmpr1a expression was maintained in the ventral
neuroepitheliumand co-expressionwithBmpr1b appeared in the dorsal
neuroepithelium (compare Figs. 5F and I). These various expression
patterns suggest that in the dorsal neuroepithelium, an active bmpr1b
signalling is occurring until late stages of chick development possibly in
correlation with the development of dorsal neurons. In contrast, in the
chick intermediate and ventral-most neuroepithelial region, an active
Bmpr1a signalling takes place around E6, at the time when APs
massively migrate into the mantle layer.
Discussion
The spatial restriction, time of speciﬁcation and signalling
mechanisms involved in the generation of astrocytes from immature
neural progenitors are poorly understood. In this study we show that
in the embryonic chick spinal cord, precursors populating the dorsal-
most Pax7/Pax6− domain do not generate GFAP+ astrocytes
although they have the potential to do so. In addition, endogenous
dorsal BMP signalling impedes early neuroepithelial cells from
Fig. 4. BMP4 has a dual effect during spinal cord development. A: Schematic representation of the experiment. B–I: Chick spinal cord explants dissected at E4 (B, F), E5 (C, G), E6 (D,
H), or E7 (E, I) and cultivated in control medium (B–E) or in the presence of 20 ng/ml of BMP4 protein (F–I). All explants were cultivated until their ages were equivalent to E12 and
then were subjected to a double GFAP (green), HuC/D (red) immunostaining. Under control conditions, explants of all stages contained both HuC/D-positive neurons and GFAP-
positive astrocytes (B–E). Explants dissected at E4 or E5 and treated with BMP4 protein completely lacked GFAP-positive astrocytes but contained numerous HuC/D-positive
neurons (F, G). Explants dissected at E6 or E7 and subjected to BMP4 protein contained an extensive population of GFAP-positive astrocytes together with HuC/D-positive neurons
(H, I). J: Quantiﬁcation of the effects of BMP4 protein on Huc/D and GFAP protein expression on E6 spinal cord by measuring the surface of the explants covered by HuC/D or GFAP
immunoreactivity, using Image Tool software. Asterisk: Student's t-test, signiﬁcant difference between control and treated cultures (*pb0.05, **pb0.01). K–L: Mouse spinal cord
intermediate explants, dissected at 10.5 dpc (K, M) or 13.5 dpc (L, N) cultivated under control conditions (K, L) or in the presence of 20 ng/ml of BMP4 protein (M, N) were subjected
double GFAP (green), HuC/D (red) immunostaining after culture. On 10.5 dpc explant, cultivated for 8 days in vitro (8DIV), BMP4 inhibit GFAP expression (M). However on 13.5 dpc
explants cultivated for 5 days in vitro (5 DIV), BMP4 did not inhibit GFAP expression (compare L, N). Images representative of at least 15 explants in 3 different experiments. Scale
bars represent 100 µm.
617E. Agius et al. / Developmental Biology 344 (2010) 611–620expressing astrocyte markers and producing astrocytes. Finally, new
foci of endogenous BMP signalling together with reinforcement of
BMPR1A expression appear in the intermediate and ventral-most
regions of the neuroepithelium that can be correlated in time and
place with ongoing astrocyte production.
Origin of astrocytes in embryonic the spinal cord
It is established that glial cells are generated after neurons. For
example, in the chick cervical spinal cord oligodendrocytes start to be
generated after motoneurons, precisely at E5.5 (Soula et al., 2001).
This neuro-glial switch was characterized both functionally using
explant cultures and by analyzing the expression of an early
oligodendrocyte marker O4 (Soula et al., 2001). Whether such a
switch occurs for astrocytes remains unclear. In our experiments,
autonomous production of GFAP astrocytes from mantle layerexplants started at E5 and was prominent at E7 (Fig. 1). Interestingly,
expression of NFIA, shown to link the abrogation of neurogenesis to a
generic program of gliogenesis starts around E5 in the chick spinal
cord (Deneen et al., 2006). Similarly, the transcription factor Sox9, a
gene that determines glial fate choice (Stolt et al., 2003) and early
astroglial markers GLAST (Shibata et al., 1997), FGFR3 (Pringle et al.,
2003), and wnt7b (Fig. 2) are also strongly expressed at that stage in
the neuroepithelium reinforcing the idea that gliogenesis starts
around E5. It is of particular interest that it is also between E5 and
E6 that the response of intermediate spinal cord explants to BMP
treatment shifts from inhibition to promotion of astrocyte develop-
ment. Moreover, it is also at the same period that a strong increase in
bmpr1a expression occurs in this region, correlated with robust
phosphor smad1 immunoreactivity. This is in favour of the hypothesis
that endogenous BMP signalling possibly mediated by bmpr1a could
play roles in regulating the neuronal–astroglial switch in vivo.
Fig. 5. Kinetics of endogenous BMP signalling in the developing spinal cord. Anti Phospho-Smad-1,5,8 immunostaining (A–C) or in situ hybridization against Bmpr1b (D–F), and
Bmpr1a (G–I), at E4 (A, D, G), E6 (B, E, H) and E8 (C, F, I). Inset in E: Pax7 immunostaining (red) after in situ hybridization with bmpr1b. Inset in H: olig2 immunostaining performed
after in situ hybridization. A: At E4, Phospho-Smad-1,5,8 immunoreactive domain is observed only in the dorsal neuroepithelium (arrowheads). B–C: At E6 and E8, in addition to the
dorsal domain of expression, additional domains are observed ventrally (arrows) separated by a domain devoid of signal (asterisk). D–F: bmpr1b expression is observed in the dorsal
spinal cord neuroepithelium at all stages. E: Note that the bmpr1b strong expression domain is located within the Pax7 domain. G: At E4, low expression of bmpr1a is observed in the
neuroepithelium. H: At E6, Bmpr1a expression domain is located in the ventral neuroepitheliumwith a gap of expression (arrow) where olig2 is expressed (Inset). I: At E8, Bmpr1a is
still strongly expressed in the neuroepithelium (arrowhead). Scale bars represent 100 µm.
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pression pattern studies suggest that astrocytes are not generated in
the dorsal-most spinal cord region which, concomitantly, maintains
expression of proneural genes such as ebf2 or ngn2 until late in
development (Fig. 1). A genetic fate mapping analysis, designed to
deﬁne neural lineages derived from ascl1-expressing cells, a precursor
population restricted to dl3–dl5 precursors (Liu et al., 2004b), has
shown that these cells give rise ﬁrst to neurons and later to
oligodendrocytes, but not to astrocytes (Battiste et al., 2007). Our
results using dorsal Pax7+/Pax6− explants, corresponding to dl1–
dl3 progenitors, extend these results andmight suggest that the entire
dl1–dl5 domain does not generate GFAP+ astrocytes in vivo.
Interestingly, in the E6 spinal cord the dorsal-most border of wnt7b
expression domain coincides with the ventral border of cash1/ascl1
expression domain (Agius et al., in preparation), further supporting
the idea that dorsal precursors outside the wnt7b domain do not
generate astrocytes. Analysis of early glial markers like FGFR3 have
shown that astrocytes are capable of extended migration within the
entire spinal cord (Pringle et al., 2003). Therefore it is conceivable that
mature astrocytes populating the dorsal-most region of the spinal
cord originate by migration from regions of the neuroepithelium
located below the dorsal-most domain. In our hands, absence ofastrocyte production from the dorsal-most Pax7+ domain in vitro
relies on the absence of GFAP immunolabelling. It is established that
protoplasmic astrocytes in vivo express low or undetectable levels of
GFAP (Pringle et al., 2003). Therefore, we cannot entirely exclude that
in our experiments, astrocyte lacking GFAP expression could be
generated.
BMP signalling prevents astrocyte markers expression from the dorsal
neuroepithelium
The roof plate is a well characterized source of multiple members
of the TGFβ family of proteins (Liem et al., 1997) which play
pleiotropic and sometimes opposite effects on neural development
(Liu et al., 2004a). Here we show that BMP signalling has a dual effect
on astrocytogenesis depending on the developmental status of the
responding cell. During the neurogenic period (E4–E5), BMP4
treatment inhibited expression of astrocytic markers and enhanced
neuronal differentiation (Figs. 2 and 4). Similarly, BMP4 also inhibited
GFAP expression in E4 chick spinal cord-derived neurospheres (Ch.S.,
E.A, P.C., unpublished results). This is consistent with results obtained
using isolatedneural cells fromE14.5 ratdorsal spinal cord,whereBMP4
inhibits GFAP expression without affecting neuronal development
619E. Agius et al. / Developmental Biology 344 (2010) 611–620(Chandran et al., 2003). On the other hand, at later stages when
astrocyte production takes place (E6–E7) BMP4 signalling appeared to
stimulate astrocyte lineage development (Fig. 4). This positive effect of
BMP on astrocyte development has been described on different neural
cell type suchasE17 rodent striatal cells in vitro (Gross et al., 1996) or P2
O2A cells (Mabie et al., 1997) and in vivo when BMP4 expression is
controlledby the late-activated (E16)neuron-speciﬁc enolase promoter
(Gomes et al., 2003).
The variety of BMP receptors, which can mediate various
responses, are among the possible molecular mechanisms responsible
for such multiple activities of BMPs on neural cells (Massague et al.,
2005). Panchision et al., (2001) have shown that two type I BMP
receptors, Bmpr1a and Bmpr1b are sequentially expressed in early
CNS development andmediate distinct functions, i.e. proliferation and
differentiation. In our analysis, Bmpr1b was expressed in the dorsal
neuroepithelium throughout the course of analysis and thus could be
associated with dorsal neuronal differentiation. At E8, we observed
co-expression of both receptors in the dorsal neuroepithelium (Fig. 5).
Such co-expression has been described to be responsible for neuronal
differentiation (Fig. 11 in Panchision et al., 2001) and thus may
contribute to the massive neuronal production occurring in the dorsal
spinal cord at that stage (F. Pituello, personal communication).
Loss of function studies in mice have shown that Bmpr1b loss of
function does not produce an apparent phenotype in the nervous
system (Yi et al., 2000) whereas Bmpr1a loss of function leads to
abnormal forebrain development (Davis et al., 2004). The require-
ment of each receptor in early steps of gliogenesis has not been
demonstrated but the double loss of function results in a reduction of
both astrocytes and mature oligodendrocytes in the spinal cord (See
et al., 2007) and affects dorsal neuron development (Wine-Lee et al.,
2004). However, the exact function of BMP signalling controlling this
glial phenotype is unclear, i.e. speciﬁcation, proliferation or matura-
tion of glial cell lineages, since the stage at which the phenotype is
generated has not been established. Recently, it has been shown that
BMPR1a and BMPR1b exert directly opposing effects on the initial
reactive astrocytic hypertrophy, BMPR1a loss of function leading to
defective astrocytic hypertrophy whereas BMPR1b-null mice con-
versely develop “hyperactive” reactive astrocytes (Sahni et al., 2010).
Here we show that an active BMP signalling, correlated with a strong
increase in bmpr1a expression (Figs. 5H and I) occurs precisely at the
time of onset of APs migration in the mantle layer. These observations
also suggest the interesting contention that an appropriate ligand, the
source and nature of which remain to be determined, activates
bmpr1a in this region quite remote from the dorsal aspect of the spinal
cord.
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